Cargando…
Low-dose interleukin-2 reverses chronic migraine-related sensitizations through peripheral interleukin-10 and transforming growth factor beta-1 signaling
Low-dose interleukin-2 (LD-IL-2) treatment has been shown to effectively reverse chronic migraine-related behaviors and the sensitization of trigeminal ganglion (TG) neurons through expansion and activation of peripheral regulatory T cells (Tregs) in mice. In this study, we investigated the molecula...
Autores principales: | Guo, Zhaohua, Zhang, Jintao, Liu, Xuemei, Unsinger, Jacqueline, Hotchkiss, Richard S, Cao, Yu-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207571/ https://www.ncbi.nlm.nih.gov/pubmed/35733705 http://dx.doi.org/10.1016/j.ynpai.2022.100096 |
Ejemplares similares
-
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
por: Daix, Thomas, et al.
Publicado: (2023) -
Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta
Publicado: (1995) -
Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma
por: Wu, Hao, et al.
Publicado: (2023) -
Roles of interleukins (interleukin-18 and interleukin-17a) and transforming growth factor-beta markers in the pathogenesis of diabetic kidney diseases
por: Mezher, Maysam Adnan, et al.
Publicado: (2023) -
Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.
por: Gallo, O., et al.
Publicado: (1993)